x

Nexalin Technology, Inc. (Nasdaq:NXL)

Health Care/Life Sciences • Medical Equipment/Supplies
CIK 1527352
Company

Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices helps people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.

Address
1776 Yorktown
Suite 550
Houston, Texas 77056
Employees
6
Stock Info
Close
$0.3477
Day Range
0.3295 - 0.3479
52 Week Range
0.2528 - 1.1300
Average volume
43.52K
Short Interest
8.77K (02/15/24)
% of Float Shorted
0.15%
Market Cap
$2.34M
Revenue
$1.32M
Net Income
-$1.7M
2020 Sales Growth
N/A
Rev. per Employee
$21.44K
P/E Ratio
N/A
EPS
-$0.6255
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Mark White
Director & Chief Medical Officer
David Owens MD
Chairman
Leslie Bernhard
Independent Director
Alan Kazden
Independent Director
Ben V Hu MD
SEC filings
DateFormEvent
20 Dec, 2024 S-1
8 Nov, 2024 10-Q
1 Nov, 2024 8-K
30 Oct, 2024 4
2 Oct, 2024 4
2 Oct, 2024 4/A
2 Oct, 2024 4
25 Sep, 2024 4/A
25 Sep, 2024 8-K
25 Sep, 2024 4
19 Sep, 2024 8-K
3 Sep, 2024 8-K
15 Aug, 2024 4
8 Aug, 2024 10-Q
30 Jul, 2024 8-K
29 Jul, 2024 DEF 14A
16 Jul, 2024 8-K
3 Jul, 2024 8-K
1 Jul, 2024 424B4
1 Jul, 2024 4
28 Jun, 2024 8-K
27 Jun, 2024 EFFECT
26 Jun, 2024 CORRESP
26 Jun, 2024 CORRESP
26 Jun, 2024 S-1/A
24 Jun, 2024 S-1/A
24 Jun, 2024 CORRESP
21 Jun, 2024 4
21 Jun, 2024 UPLOAD
18 Jun, 2024 8-K
14 Jun, 2024 S-1/A
12 Jun, 2024 4
12 Jun, 2024 CORRESP
5 Jun, 2024 UPLOAD
23 May, 2024 S-1
21 May, 2024 8-K
14 May, 2024 RW
10 May, 2024 10-Q
26 Apr, 2024 8-K
16 Apr, 2024 S-3
11 Apr, 2024 8-K
27 Mar, 2024 10-K
20 Mar, 2024 8-K
17 Jan, 2024 DEF 14A
13 Nov, 2023 8-K
13 Nov, 2023 10-Q
6 Oct, 2023 DEF 14A
5 Oct, 2023 4
5 Oct, 2023 4
5 Oct, 2023 4
5 Oct, 2023 4
28 Sep, 2023 8-K
10 Aug, 2023 10-Q
30 Jun, 2023 4/A
30 Jun, 2023 4/A
30 Jun, 2023 3/A
30 Jun, 2023 3/A
30 Jun, 2023 4/A
2 Jun, 2023 8-K
16 May, 2023 8-K
10 May, 2023 10-Q
27 Mar, 2023 10-K
10 Nov, 2022 10-Q
3 Oct, 2022 8-K
29 Sep, 2022 4
22 Sep, 2022 4/A
20 Sep, 2022 4
20 Sep, 2022 4
20 Sep, 2022 4
20 Sep, 2022 8-K/A
20 Sep, 2022 8-K
20 Sep, 2022 4
20 Sep, 2022 4
19 Sep, 2022 3
19 Sep, 2022 424B4 IPO completed
19 Sep, 2022 3
19 Sep, 2022 3
19 Sep, 2022 3
19 Sep, 2022 3
19 Sep, 2022 3
16 Sep, 2022 8-K
16 Sep, 2022 CERT
15 Sep, 2022 8-A12B
15 Sep, 2022 S-1/A
15 Sep, 2022 S-1/A
15 Sep, 2022 EFFECT
12 Sep, 2022 CORRESP
12 Sep, 2022 CORRESP
24 Aug, 2022 S-1/A
31 May, 2022 S-1/A
31 May, 2022 CORRESP
16 May, 2022 S-1/A
16 May, 2022 CORRESP
6 May, 2022 UPLOAD
28 Apr, 2022 S-1/A
27 Apr, 2022 CORRESP
22 Apr, 2022 UPLOAD
8 Apr, 2022 S-1/A
8 Apr, 2022 CORRESP
9 Feb, 2022 UPLOAD
4 Feb, 2022 S-1/A
31 Jan, 2022 S-1/A
19 Jan, 2022 UPLOAD
4 Jan, 2022 S-1
21 Dec, 2021 UPLOAD
8 Dec, 2021 DRS/A
19 Nov, 2021 UPLOAD
2 Nov, 2021 DRS/A
15 Oct, 2021 UPLOAD
17 Sep, 2021 DRS
Last update:2024-03-06 12:45:35.336155

Sign Up to Subscribe